首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess
【2h】

Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess

机译:溶血性变形虫Gal / GalNAc凝集素中间亚基C末端片段作为抗阿米巴肝脓肿的疫苗候选者的评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEntamoeba histolytica is an intestinal protozoan parasite that causes amoebiasis, including amebic dysentery and liver abscesses. E. histolytica invades host tissues by adhering onto cells and phagocytosing them depending on the adaptation and expression of pathogenic factors, including Gal/GalNAc lectin. We have previously reported that E. histolytica possesses multiple CXXC sequence motifs, with the intermediate subunit of Gal/GalNAc lectin (i.e., Igl) as a key factor affecting the amoeba's pathogenicity. The present work showed the effect of immunization with recombinant Igl on amebic liver abscess formation and the corresponding immunological properties.
机译:背景溶组织阿米巴虫是引起阿米巴病(包括阿米巴痢疾和肝脓肿)的肠道原生动物寄生虫。溶组织性大肠杆菌通过粘附到细胞上并吞噬细胞来侵入宿主组织,具体取决于致病因子(包括Gal / GalNAc凝集素)的适应性和表达。我们以前曾报道过,溶组织性大肠杆菌具有多个CXXC序列基序,其中Gal / GalNAc凝集素的中间亚基(即Igl)是影响变形虫致病性的关键因素。目前的工作表明重组Igl免疫对阿米巴肝脓肿的形成及其相应的免疫学特性。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号